Skip to main content
. 2019 May 29;11(6):747. doi: 10.3390/cancers11060747

Table 1.

Molecular characteristics of the histone deacetylase inhibitor (HDACis) used.

Group Compound Chemical Structure HDAC Specificity
Hydroxamate Vorinostat (SAHA) graphic file with name cancers-11-00747-i001.jpg class I and II HDACs
Trichostatin A (TSA) graphic file with name cancers-11-00747-i002.jpg class I and II HDACs
MC1568 graphic file with name cancers-11-00747-i003.jpg Class II HDACs
Benzamide Entinostat (MS275) graphic file with name cancers-11-00747-i004.jpg HDAC 1 and HDAC 3 (class I HDACs members)